| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/07/1998 | WO1998008856A3 Mirror-symmetrical selection and evolution of nucleic acids |
| 05/07/1998 | WO1998008517A3 Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol |
| 05/07/1998 | WO1998007415A3 Methods for prevention of cellular proliferation and restenosis |
| 05/07/1998 | WO1998005360A3 Use of (meth)acrylic acid copolymers to increase the permeability of mucous membranes |
| 05/07/1998 | WO1998005331A3 Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators |
| 05/07/1998 | WO1998005323A3 Method of regulating the female reproductive system through angiogenesis inhibitors |
| 05/07/1998 | WO1998004242A3 Tumor delivery vehicles and method to enhance treatment of cystic tumors |
| 05/07/1998 | WO1998001125A3 Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity |
| 05/07/1998 | WO1998000173A3 Targeted drug delivery using sulfonamide derivatives |
| 05/07/1998 | WO1997044461A3 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/07/1998 | DE19645313A1 Substituierte 3-Benzylpyrazole Substituted 3-benzylpyrazoles |
| 05/07/1998 | DE19645044A1 Verwendung von Ursodeoxycholsäure zur topischen Behandlung von Entzündungserkrankungen der Schleimhäute Use of ursodeoxycholic acid for the topical treatment of inflammatory diseases of the mucous membranes |
| 05/07/1998 | DE19643831A1 Medicament for treating azole-resistant fungal infections |
| 05/07/1998 | DE19643790A1 Benzoxazol-Derivat Benzoxazole derivative |
| 05/07/1998 | CA2665133A1 Neutrokine .alpha. |
| 05/07/1998 | CA2270433A1 Synthesis of benzo¬f|quinolinones |
| 05/07/1998 | CA2270373A1 Synergistic composition comprising rapamycin and calcitriol |
| 05/07/1998 | CA2270359A1 Benzoaxozole derivative |
| 05/07/1998 | CA2270345A1 Immunostimulatory nucleic acid molecules |
| 05/07/1998 | CA2270254A1 Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators |
| 05/07/1998 | CA2270174A1 Pharmaceutical compositions containing lamivudine and zidovudine |
| 05/07/1998 | CA2270138A1 Antimalarial compositions containing cis-fused cyclopenteno-1,2,4-trioxane derivatives |
| 05/07/1998 | CA2270123A1 Compounds, compositions and methods for treating antibiotic-resistant infections |
| 05/07/1998 | CA2270120A1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/07/1998 | CA2270119A1 Drugs for ameliorating ocular circulatory disorders |
| 05/07/1998 | CA2270113A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2270111A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2270057A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2270056A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2270055A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2269985A1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/07/1998 | CA2269974A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2269973A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2269970A1 Novel (+)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2269936A1 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
| 05/07/1998 | CA2269814A1 2-methoxyphenylpiperazine derivatives |
| 05/07/1998 | CA2269722A1 Oligomers which inhibit the expression of interleukin genes |
| 05/07/1998 | CA2269720A1 Novel heterocyclic amide compound and pharmaceutical use thereof |
| 05/07/1998 | CA2269670A1 A method for lowering plasma levels of lipoprotein(a) |
| 05/07/1998 | CA2269660A1 Combination therapy for the treatment of diabetes and obesity |
| 05/07/1998 | CA2269328A1 Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use as noncompetitive antagonists of dopamine reuptake |
| 05/07/1998 | CA2269213A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna |
| 05/07/1998 | CA2269203A1 Substituted tricyclics |
| 05/07/1998 | CA2269135A1 Benzodiazepine hydrazide derivatives as inhibitors of hiv integrase |
| 05/07/1998 | CA2269095A1 2-pyrimidineamine derivatives and processes for their preparation |
| 05/07/1998 | CA2268942A1 Methods of treating or preventing cardiac arrhythmia |
| 05/07/1998 | CA2268940A1 Integrin antagonists |
| 05/07/1998 | CA2268916A1 Integrin antagonists |
| 05/07/1998 | CA2268838A1 Thienylcyclohexanone derivatives as ligands of the gabaa .alpha.5 receptor subtype |
| 05/07/1998 | CA2268820A1 Stabilized carbapenem antibiotic compositions and method of making |
| 05/07/1998 | CA2268738A1 Conjugates useful in the treatment of prostate cancer |
| 05/07/1998 | CA2268546A1 Composition, for the treatment of asthma, containing loratadine and a decongestant |
| 05/07/1998 | CA2266514A1 Novel (alpha-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof |
| 05/07/1998 | CA2265523A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
| 05/07/1998 | CA2263334A1 Fatty acid esters of lactic acid salts as permeation enhancers |
| 05/07/1998 | CA2263300A1 Fatty acid esters of glycolic acid and its salts as permeation enhancers |
| 05/07/1998 | CA2241687A1 P2y receptor antagonists |
| 05/07/1998 | CA2241626A1 Riboflavin mutants as vaccines against actinobacillus pleuropneumoniae |
| 05/07/1998 | CA2241458A1 Compositions for the treatment of renal failure, comprising l-carnosine |
| 05/07/1998 | CA2218735A1 Cosmetic composition in the form of a transparent foaming gel |
| 05/06/1998 | EP0839831A2 Single chain gonadotropin |
| 05/06/1998 | EP0839830A1 Polyether nucleic acids |
| 05/06/1998 | EP0839827A1 Novel polyhydro derivatives of tylosine and process for their preparation |
| 05/06/1998 | EP0839814A2 Indolocarbazole derivatives and their use for the treatment of prostate gland disorders |
| 05/06/1998 | EP0839807A1 Synthesis of benzo(f)quinolinones |
| 05/06/1998 | EP0839806A1 Substituted tricyclics |
| 05/06/1998 | EP0839805A1 Pyrrolidinone derivatives and their use as antipsychotic medicaments |
| 05/06/1998 | EP0839798A2 Intermediates for preparating non-peptide retroviral protease inhibitors |
| 05/06/1998 | EP0839534A1 Pharmacological association between n-acetylcystein and levulose for preventing cellular death and related diseases |
| 05/06/1998 | EP0839533A1 Methods of preventing breast cancer by the administration of Raloxifene |
| 05/06/1998 | EP0839532A1 Improvements in or relating to the prophylaxis of breast cancer by the administration of raloxifene |
| 05/06/1998 | EP0839531A1 Use of ellagic acid in the manufacture of a medicament for the treatment of duodenal or gastric ulcer |
| 05/06/1998 | EP0839530A1 Use of ellagic acid in the manufacture of a medicament for stimulating gastrointestinal motility |
| 05/06/1998 | EP0839529A2 Compositions containing aliphatic monocarboxylic acid esters or amides for the treatment of skin diseases |
| 05/06/1998 | EP0839528A1 Mouth-soluble compositions containing N-acetylcysteine and cyclodextrin |
| 05/06/1998 | EP0839520A1 Rinsing composition for the care of the skin |
| 05/06/1998 | EP0839514A1 Hair treating composition with long-lasting fixing properties |
| 05/06/1998 | EP0839458A1 Phytosterol compositions and their production |
| 05/06/1998 | EP0839206A1 Cd4 gene regulatory sequences specifically expressed in mature t cells |
| 05/06/1998 | EP0839196A2 Human ctla-8 and uses of ctla-8-related proteins |
| 05/06/1998 | EP0839195A1 Nucleotide and peptide sequences for treating myasthenia |
| 05/06/1998 | EP0839194A1 Protein p53 variants and their therapeutic uses |
| 05/06/1998 | EP0839159A1 Polysaccharide gel composition |
| 05/06/1998 | EP0839157A1 Colostrum derived growth factor |
| 05/06/1998 | EP0839155A1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES |
| 05/06/1998 | EP0839149A1 Galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
| 05/06/1998 | EP0839148A1 (r)-(z)-1-azabicyclo 2.2.1]heptan-3-one,o- 3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent |
| 05/06/1998 | EP0839147A1 New oxazolidinone derivatives, process for preparing the same and medicaments that contain these compounds |
| 05/06/1998 | EP0839146A1 Piperazine derivatives and their use as 5-ht1a antagonists |
| 05/06/1998 | EP0839145A1 Heterocyclylcarboxamide derivatives and their use as therapeutic agents |
| 05/06/1998 | EP0839144A1 Piperazine derivatives as therapeutic agents |
| 05/06/1998 | EP0839143A1 Tetralin compounds with mdr activity |
| 05/06/1998 | EP0839140A1 Tribenzimidazoles useful as topoisomerase i inhibitors |
| 05/06/1998 | EP0839137A1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 05/06/1998 | EP0839136A1 BENZO[g]QUINOLINE DERIVATIVES |
| 05/06/1998 | EP0839134A1 Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| 05/06/1998 | EP0839133A1 4,9-ethano-benzo(f)isoindole derivatives as farnesyl transferase inhibitors |
| 05/06/1998 | EP0839132A1 Novel process for the production of amorphous [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 05/06/1998 | EP0839055A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
| 05/06/1998 | EP0839053A2 Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor |